Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gozzetti

Showing results (101-110 of 212) with videos related to

Pageof 22
Sort By:
Hematology (Amsterdam, Netherlands)|December 21, 2006
Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?Serena Mazzotta, Roberto Guerranti, Alessandro Gozzetti, et al.
European Journal of Immunology|May 9, 2022
Assessing gene function in human B cells: CRISPR/Cas9-based gene editing and mRNA-based gene expression in healthy and tumor cellsFederica Nardi, Laura Pezzella, Roberta Drago, et al.
Cancer Genetics and Cytogenetics|December 11, 2007
Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogeneticsAlessandro Gozzetti, Monica Bocchia, Rosaria Crupi, et al.
The Lancet. Oncology|October 5, 2007
Insights into JAK2-V617F mutation in CMLMonica Bocchia, Alessandro M Vannucchi, Alessandro Gozzetti, et al.
Genes, Chromosomes & Cancer|May 13, 2004
Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangementsIdoya Lahortiga, Iria Vázquez, Xabier Agirre, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal AntibodiesFederico Caroni, Vincenzo Sammartano, Paola Pacelli, et al.
Frontiers in Oncology|July 25, 2022
Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical GuidanceVincenzo Sammartano, Alfonso Cerase, Valentina Venanzi, et al.
Leukemia Research and Treatment|December 1, 2012
Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patientsMicaela Ippoliti, Marzia Defina, Antonella Gozzini, et al.
American Journal of Blood Research|April 2, 2021
First reported case of secondary mixed phenotype acute leukemia after multiple myelomaFrancesca Bacchiarri, Vincenzo Sammartano, Adele Santoni, et al.
Haematologica|September 10, 2002
Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical studyMichele Cavo, Monica Benni, Sonia Ronconi, et al.
Pageof 22

Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
Hematology (Amsterdam, Netherlands)|December 21, 2006
Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?Serena Mazzotta, Roberto Guerranti, Alessandro Gozzetti, et al.
European Journal of Immunology|May 9, 2022
Assessing gene function in human B cells: CRISPR/Cas9-based gene editing and mRNA-based gene expression in healthy and tumor cellsFederica Nardi, Laura Pezzella, Roberta Drago, et al.
Cancer Genetics and Cytogenetics|December 11, 2007
Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogeneticsAlessandro Gozzetti, Monica Bocchia, Rosaria Crupi, et al.
The Lancet. Oncology|October 5, 2007
Insights into JAK2-V617F mutation in CMLMonica Bocchia, Alessandro M Vannucchi, Alessandro Gozzetti, et al.
Genes, Chromosomes & Cancer|May 13, 2004
Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangementsIdoya Lahortiga, Iria Vázquez, Xabier Agirre, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal AntibodiesFederico Caroni, Vincenzo Sammartano, Paola Pacelli, et al.
Frontiers in Oncology|July 25, 2022
Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical GuidanceVincenzo Sammartano, Alfonso Cerase, Valentina Venanzi, et al.
Leukemia Research and Treatment|December 1, 2012
Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patientsMicaela Ippoliti, Marzia Defina, Antonella Gozzini, et al.
American Journal of Blood Research|April 2, 2021
First reported case of secondary mixed phenotype acute leukemia after multiple myelomaFrancesca Bacchiarri, Vincenzo Sammartano, Adele Santoni, et al.
Haematologica|September 10, 2002
Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical studyMichele Cavo, Monica Benni, Sonia Ronconi, et al.
Pageof 22